BX-1 in Spasticity Due to Multiple Sclerosis

NCT03756974 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

397

Enrollment

INDUSTRY

Sponsor class

Conditions

Spasticity Due to Multiple Sclerosis

Interventions

DRUG: BX-1
DRUG: Placebo

Sponsor

Bionorica SE